Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.
Day 3

DISCOVER Trial: Results at one year of the new nonmetallic percutaneous aortic valve

solaci
solaci
524
0

Direct Flow Medical prosthesis is a nonmetallic, repositionable, recaptured valve (even after posts dilate), that does not require a pacemakers use during both implantation and post-dilatation. 

The aim of this study was to evaluate new valve results to one year in patients with symptomatic severe aortic stenosis with 19 and 26 mm ring, EuroScore of at least 20 and comorbidities. 100 patients showed one-year survival of 90% and mild aortic regurgitation or even less were included. 

J. Schofer
2014-05-23

Title: The DISCOVER trial: 1-year outcomes of a new-generation non metallic transcatheter aortic valve

Previous article
POST -IT: The FFR modifies strategy in almost half of patients
Next article
UK TAVI Registry: Long-term results of TAVI in the UK
solaci
solaci

More articles by this author

SOURCE XT: Results at 2 years of SAPIEN XT valve

solaci - 0
Multicenter prospective study included 2688 patients with a mean age of 81.4 years and 20.5 EuroScore. The all-cause mortality at 2 years was 27.7%...

NOBORI II: Final 5-year results of drug-eluting stent with bio-absorbable polymer

solaci - 0
This study evaluated the performance of Nobori biolimus bio-absorbable polymer stent in real-world patients. A total of 3067 consecutive patients followed up to 5...

TRYTON dedicated bifurcation stent in left main coronary artery

solaci - 0
TRYTON is a cobalt chromium device specifically dedicated for bifurcation lesions to be implanted in the side branch. Circumflex artery is the major lateral...

UK TAVI Registry: Long-term results of TAVI in the UK

solaci - 0
This record has been created in order to evaluate the results of percutaneous aortic valve replacement in the UK and currently includes more than...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Day 3

SOURCE XT: Results at 2 years of SAPIEN XT valve

Multicenter prospective study included 2688 patients with a mean age of 81.4 years and 20.5 EuroScore. The all-cause mortality at...
solaci -
SOLACI Sessionsspot_img

Recent Articles

Percutaneous Closure of Patent Foramen Ovale in Patients Over 60 Years Old With Cryptogenic Stroke: A Safe and Effective Strategy?

Dr. Juan Manuel Pérez - 0
Cryptogenic stroke accounts for up to one-third of all ischemic strokes and remains strongly associated with the presence of a patent foramen ovale (PFO),...

Left Atrial Appendage Closure: Implantation Depth Could Determine Thrombosis Risk

Dr. Andrés Rodríguez - 0
Left atrial appendage closure (LAAC) has undergone significant advances over the past two decades. This progress has been driven by the development of new...

Influence of cusp-overlap and three-cusp coplanar techniques on new-onset conduction disturbances after TAVI

Dr. Juan Manuel Pérez - 0
New-onset conduction disturbances remain one of the most frequent complications after transcatheter aortic valve implantation (TAVI), being associated with worse long-term clinical outcomes. Among...